Inhibition of AKT/mTOR signaling promotes autophagy and sensitizes tumor cells to anticancer drugs by reducing cell growth, cell cycle, cell survival, differentiation, and metabolism (Paquette et al., 2018; Terracciano et al., 2019). Here, MTOR is linked to neoplasm.